With 7.3% of CAGR, Bioreactors Market to Gain $5.1 Billion Revenue by 2027 | The Insight Partners

Bioreactors market size is witnessing steady growth due to increased acceptance of single-use bioreactors, rapid growth of pharmaceutical and biotechnology industry, growing investments in R&D & other activities, and technological advancements in bioreactors.

New York, Nov. 22, 2022 (GLOBE NEWSWIRE) — According to The Insight Partners latest study titled “Bioreactors Market Size, Share, Growth, Trends and Forecast to 2027– COVID-19 Impact and Global Analysis – by Product Class, Application, Process, and Geography,” the global bioreactors market was valued at USD 2.9 billion in 2019 and is projected to reach USD 5.1 Billion by 2027; it is estimated to grow at a CAGR of 7.3% from 2020 to 2027. 

Download Sample PDF Brochure of Bioreactors Market Size – COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPHE100000880/

Global Bioreactors Market Report Scope, Segmentations, Regional & Country Scope:

Report Coverage	Details
Market Size Value in	USD 2.9 Billion in 2019
Market Size Value by	USD 5.1 Billion by 2027
Growth rate	CAGR of 7.3% from 2020 to 2027
Forecast Period	2020-2027
Base Year	2019
No. of Pages	194
No. of Tables	141
No. of Charts & Figures	85
Historical data available	Yes
Segments covered	Cell, Molecule, Technology, End User, and Geography
Regional scope	North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

In 2019, North America held the largest share of the bioreactors market. The regional market growth is characterized by increasing demand for bioreactor systems from biopharmaceutical and biotechnology companies, presence of key market players, extensive R&D conducted by various academic and research institutes, and immense research by pharmaceutical and biotechnology companies. Increasing number of market players launching new products and adoption of organic and inorganic strategies by manufacturers and distributors also accelerate the market growth. A large number of market players are manufacturing bioreactors for a wide range of applications in pharmaceutical and biotechnology companies. Launch of new bioreactors, geographic expansion, and partnerships by market players add impetus to the market growth. In March 2018, Pall Corporation launched iCELLis nano bioreactor system for small-scale production of virus for vaccines or gene therapy applications. In March 2018, Sartorius AG launched ambr 250 high throughput (ht) perfusion, an automated bioreactor system for rapid cell culture perfusion process development, thereby optimizing the production of therapeutic antibodies. The growing biopharmaceutical sector characterized by technological advancements, increasing flexibility, and low operational cost also fuels the market growth.

Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPHE100000880/

Global Bioreactors Market: Competitive Landscape and Key Developments

Key players operating in the bioreactors market are Thermo Fisher Scientific Inc., Applikon Biotechnology BV, Merck KGaA, Sartorius AG, Eppendorf, General Electric, Bioengineering AG, Solaris Biotechnology Srl, Danaher (Pall Corporation), and Praj Industries. They focus on expanding the business, diversifying their market presence, and acquiring a novel customer base, thereby tapping into prevailing business opportunities.

In April 2018, Sartorius Stedim Biotech launched the advanced mini bioreactor vessel for ambr 250 high throughput (ht) system. The new bioreactor helps grow adherent cells on micro carriers that will enable rapid and scalable cell culture process development of vaccines. The launch enhanced the company’s portfolio in the biotechnology market.

In October 2017, Eppendorf India extended its training center facility in Ambattur, Chennai. The center equipped with laboratories for cell cultivation and bioprocess applications offers training in three competence areas of liquid, sample, and cell handling. 

In September 2018, Infors AG launched the second generation of Minifors bench-top bioreactor. This product allows beginners and experienced users get a complete package for the cultivation of microorganisms to perform bioprocesses with ease.

In May 2017, Sartorius Stedim Biotech signed an agreement with Nova Biomedical (US) for the integration of BioProfile FLEX2 into ambr multi-parallel bioreactor systems for automated, at-line cell culture analytics. The agreement aims at developing well-characterized cell culture processes in less time while preventing the process development bottleneck being shifted to the analytical laboratory.

Increasing Acceptance of Single-Use Bioreactors is Boosting Bioreactors Market

Various manufacturers have developed robust, high-performance single-use bioreactors (SUBs) necessary for commercial manufacturing of biopharmaceuticals. Several advantages offered in film technologies, bioreactor designs, stirring mechanisms, and sensor systems have contributed to the increasing adoption of disposable reactors from lab to production scale. Single-use bioreactors are helpful in providing next-generation cell and gene therapies and continuous bioprocessing. Improvements in cell culture processes have developed higher titers and cell densities, facilitating the adoption of single-use bioreactors through reductions in required reactor volumes.

Have a Question? Speak to Research Expert: https://www.theinsightpartners.com/speak-to-analyst/TIPHE100000880/

Single-use bioreactors reduce the risk of contamination from other products and decrease production turnaround times. Nowadays, manufacturers are interested in 2,000L bioreactors for large-scale production. The SUBs combine elements of stirred-tank systems with efficiencies of cleanup and validation found in single-use processing and supports scale-up needs and optimal cell growth, viability, and general metabolism.

The single-use technologies have gained widespread acceptance with the support from regulators. Although existing cGMP processes adopt stainless steel infrastructure, many new products are directly used into single-use production equipment. The increasing acceptance of SUBs is leading to the rising production of bioreactors and subsequently driving its market expansion.

Bioreactors Market: Segmental Overview

Based on product class, the bioreactors market is segmented into benchtop (upto 15L), pilot scale (15–1000L), and industrial scale (>1000L). The industrial segment held the largest market share in 2018. The pilot scale segment is expected to register the highest CAGR during the forecast period.

The global bioreactors market, based on application, is segmented into microbial and cell culture, each divided into multiple use and single use, based on the type of bioreactor used. By application, the microbial application segment held the largest share of the market in 2018 and is expected to grow at the fastest rate during the coming years.

The global bioreactors market, based on process, is segmented into classified as research & development, process development, and bioproduction. By process, the bioproduction segment held the largest share of the market in 2018 and is expected to grow at the fastest rate during the coming years.

Quickly Purchase Premium Copy of Bioreactors Market Growth Report (2020-2027) at: https://www.theinsightpartners.com/buy/TIPHE100000880/

Browse Related Reports:

Single Use Bioreactors Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Single-Use Bioreactors System, Single-Use Media Bag, Single-Use Filtration Assemblies , Other); Type (Stirred Tank Single-Use Bioreactors, Bubble Column Single-Use Bioreactors, Wave Induced Single-Use Bioreactors); Molecule type (Monoclonal Antibodies, Vaccine, Stem Cells, Gene Modified Cells, Other Molecules); Cell Type (Mammalian Cells, Bacteria Cells, Yeast Cells, Other Cells); Application (Research and Development, Process Development, Bio Production , Other); End-User (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)) and Geography

Micro-Bioreactors Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Type (48 Parallel Bioreactors, 24 Parallel Bioreactors, and Others); Application (Pharmaceutical, Sewage Treatment, Biochemical Engineering, Food Industry, and Others); End Use (Pharmaceutical and Biopharmaceutical Industry, Biotechnology Industry, Academic Institutions, and Others), and Geography

Portable Bioprocessing Bioreactors Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Capacity (1-10L, 10-50L, 50-100L, 100-500L); Material (Glass, Stainless Steel, Single-Use); Control Type (Automate, Manual); End User (Biopharmaceuticals Industry, Academic Institute, Research Laboratories) and Geography

Bench-Top Bioreactors Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Material (Glass, Stainless Steel, Single-Use); Type (Autoclavable, Sterilize-in-Place); Scale (0-50ML, 50-100ML, 100-250ML, Above 250 ML); Application ( Microbial, Cell Culture); End User (Biopharmaceutical Companies, CROs, Academic and Research Institutes, Others), and Geography

Bioprocess Validation Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter Element, Bioreactors), End-User (CDMO, Biotechnology & Pharmaceutical Companies) and Geopgraphy

Upstream Bioprocessing Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Bioreactors, Cell Culture, Filters, Bags And Containers, Others); Workflow (Media Preparation, Cell Culture, Cell Separation); Use Type (Multi-use, Single-use); Mode (In-house, Outsourced) and Geography

Bubble Column Bioreactor Market Forecast to 2028 –  Covid-19 Impact and Global Analysis – by Product Types (Mammalian Cells, Bacteria, Yeast, Others); Applications (Research and Development, Process Development, Bioproduction), and Geography

Biosensor Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Application (Medical, Agriculture, Bioreactor); Technology (Thermal, Electrochemical, Piezoelectric, Optical); End User (Home Healthcare Diagnostics, PoC Testing, Food Industry, Research Laboratories, Security and Bio-defence)

Antibody Production Market Forecast to 2028 –  Covid-19 Impact and Global Analysis – By Type (Monoclonal, Polyclonal); Device (Bioreactors, Chromatography, Consumables); End User (Biopharmaceutical/Pharmaceutical Companies, Research & Academic Institutes, Diagnostic Laboratories) and Geography

Perfusion Systems Market to 2027- Global Analysis and Forecasts by Type (Microfluidic Perfusion Systems, Small-Mammal Organ Perfusion Systems, Bioreactor Perfusion Systems, gravity or Pressure-Driven Perfusion Systems); Component (Perfusion Pumps, Oxygenators, Herat-Lung Machines, Monitoring Systems, Cannulas and Others) and Geography

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/bioreactors-market

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.